Who invested in OncoResponse?
OncoResponse's investors include GreatPoint Ventures, Canaan, ARCH Venture Partners, Redmile Group and Arch, and 6 more on record.
United States · Series D startup
Funding summaryUpdated 26 Oct 2026
$44Mraised across 3 rounds since 2016, from 3 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Source recordedSEC filing: $14M sold, first sale May 2023
Reported by FinSMEsSEC filing: $29M sold, first sale Sept 2015
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
OncoResponse's investors include GreatPoint Ventures, Canaan, ARCH Venture Partners, Redmile Group and Arch, and 6 more on record.
OncoResponse has raised $44M across 3 rounds since 2016.
OncoResponse's most recent round was a Series D of $14M in May 2023.
OncoResponse's largest round on record is $23M (Series A), in Mar 2017.
OncoResponse's first round on record, in Oct 2016, was backed by GreatPoint Ventures.
OncoResponse's latest named round is a Series D, in May 2023.
OncoResponse is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.